View in EDS HTML Full Text PDF Full Text

Associations of 18F-RO-948 tau PET with fluid AD biomarkers, Centiloid, and cognition in early AD continuum.

Saved in:
Bibliographic Details
Title: Associations of 18F-RO-948 tau PET with fluid AD biomarkers, Centiloid, and cognition in early AD continuum.
Authors: Shekari M; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Escalante AG; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Milà-Alomà M; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain., Falcon C; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina; (CIBERBBN), Instituto de Salud Carlos III, Madrid, Spain., López-Martos D; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain., Sánchez-Benavides G; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain., Brugulat-Serrat A; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.; Global Brain Health Institute, San Francisco, California, USA., Niñerola-Baizán A; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina; (CIBERBBN), Instituto de Salud Carlos III, Madrid, Spain.; Nuclear Medicine Department, Hospital Clínic Barcelona - IDIBAPS, Barcelona, Spain., Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Banner Alzheimer's Institute and University of Arizona, Phoenix, Arizona, USA.; Banner Sun Health Research Institute, Sun City, Arizona, USA., Karikari TK; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Lantero-Rodriguez J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Montoliu-Gaya L; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Snellman A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Turku PET Centre, University of Turku, Turku, Finland., Day TA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Dage JL; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA., Ortiz-Romero P; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain., Tonietto M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Borroni E; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Klein G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kollmorgen G; Roche Diagnostics GmbH, Penzberg, Germany., Carboni M; Roche Diagnostics International Ltd, Rotkreuz, Switzerland., Quijano-Rubio C; Roche Diagnostics International Ltd, Rotkreuz, Switzerland., Vanmechelen E; ADx NeuroSciences, Ghent, Belgium., Minguillón C; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain., Fauria K; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain., Perissinotti A; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina; (CIBERBBN), Instituto de Salud Carlos III, Madrid, Spain.; Nuclear Medicine Department, Hospital Clínic Barcelona - IDIBAPS, Barcelona, Spain., Molinuevo JL; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Novartis Institutes for BioMedical Research, Translational Medicine, Neuroscience, Basel, Switzerland., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute at UCL, London, UK., Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden., Grau-Rivera O; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.; Servei de Neurologia, Hospital del Mar, Barcelona, Spain., Suárez-Calvet M; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.; Hospital del Mar Research Institute (HMRI), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.; Servei de Neurologia, Hospital del Mar, Barcelona, Spain., Gispert JD; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Corporate Authors: ALFA Study
Source: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2026 Apr; Vol. 22 (4), pp. e71176.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1552-5279
DOI:10.1002/alz.71176